1. Kihara K, Koga F, Masuda H, Saito K, Tatokoro M, Yokoyama M, Matsuoka Y, Numao N, Kawakami S, Fujii Y. Feasibility of gasless single-port clampless partial nephrectomy for peripheral renal tumor: An experience of 118 consecutive cases. "Best Poster Presentation" The 27th Annual Congress of the European Association of Urology， Paris, France, 2012/2/27.

2. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Kobayashi S, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Koga F, Masuda H, Kihara K. Candidate selection for hemiablative focal therapy of prostate cancer through a combination of extended 14-core biopsy and MRI. "Best Poster Presentation" The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

3. Tatokoro M, Masuda H, Kijima T, Yoshida S, Sakura M, Yokoyama M, Saito K, Koga F, Fujii Y, Kawakami S, Kihara K. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus Aureus (MRSA) in a urology ward possibly due to avoidance of antimicrobial prophylaxis in minimally invasive surgery: Our 11-year trial. "Best Poster Presentation" The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25．

4. Kobayashi S, Fujii Y, Koga F, Yokoyama M, Sakura M, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H, Kihara K. Impact of bladder neck involvement on progression in patients with non-muscle invasive bladder cancer: a validation study. "Best Poster Presentation" The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

5. Numao N. International Journal of Urology Reviewer of the Year 2011. Awarded by Japanese Urological Association, 2012.

6. 松岡　陽、沼尾　昇、齋藤一隆、田中　宏、木島敏樹、小林秀一郎、田所　学、砂倉瑞明、横山みなと、石岡淳一郎、古賀文隆、増田　均、木原和徳. 前立腺14ヵ所生検とMRIは片側部分治療の適格症例を高い精度で予測する. 「第100回日本泌尿器科学会総会 総会賞」. 【第100回日本泌尿器科学会総会 総会賞】 2012年4月21日.

7. 河野友亮、福井直隆、影山幸雄、東　四雄． エンドトキシン吸着療法により救命しえたＥＳＢＬ産生菌による経直腸前立腺針生検後の重症感染症の1例． 【第62回日本泌尿器科学会埼玉地方会ベストプレゼンテーション賞】 2012年11月10日．

欧州泌尿器科学会（European Association of Urology annual congress）

1. Kihara K, Koga F, Masuda H, Saito K, Tatokoro M, Yokoyama M, Matsuoka Y, Numao N, Kawakami S, Fujii Y. Feasibility of gasless single‐port clampless partial nephrectomy for peripheral renal tumor: An experience of 118 consecutive cases. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

2. Kihara K, Masuda H, Saito K, Koga F, Numao N, Matsuoka Y, Ishioka J, Yokoyama M, Sakura M, Fujii Y. Gasless laparoendoscopic single-port retroperitoneal radical nephrectomy for renal tumors in dialysis patients: perioperative outcomes of 81 consecutive cases. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

3. Yokoyama M, Fujii Y, Takeshita H, Sakura M, Ishioka J, Iimura Y, Saito K, Koga F, Masuda H, Noro A, Kihara K. Novel nomogram and formula to predict renal function after radical nephrectomy. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

4. Takeshita H, Yokoyama M, Fujii Y, Chiba K, Ishioka J, Saito K, Koga F, Masuda H, Noro A, Kihara K. Impact of renal function immediately after radical nephrectomy on cardiovascular events in patients with kidney cancer. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

5. Sakura M, Masuda H, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Koga F, Saito K, Kihara K. Can diffusion weighted magnetic resonance imaging detect renal cell carcinoma in dialysis patient with acquired cystic disease of kidney? The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

6. Numao　N, Yoshida S, Komai Y, Ishii C, Kagawa M, Takeshita H, Nakanishi Y, Kijima T, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Matsuoka Y, Koga F, Saito K, Masuda H, Kawakami S, Kihara K Prebiopsy multi-parametric MRI can substantially reduce unnecessary prostate biopsy in men with PSA less than 10 ng/mL and a normal digital rectal examination. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

7. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Kobayashi S, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Koga F, Masuda H, Kihara K. Candidate selection for hemiablative focal therapy of prostate cancer through a combination of extended 14-core biopsy and MRI. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

8. Fukushima H, Masuda H, Kawakami S, Ito M, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yonose J, Fukui I, Kihara K. Positive association between diabetes mellitus and high grade prostate cancer detection via extended prostate biopsy in obese Japanese men with PSA less than 10 ng/ml. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

9. Koga F, Yoshida S, Kobayashi S, Ishii C, Tanaka H, Fujii Y, Tanaka H, Masuda H, Saito K, Komai Y, Kawakami S, Kihara K. Diffusion‐weighted MRI predicts sensitivity to chemoradiation in muscle‐invasive bladder cancer. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

10. Tatokoro M, Koga F, Yoshida S, Fukushima H, Kawakami S, Fujii Y, Neckers L, Kihara K. Potential role of Hsp90 Inhibitors in overcoming cisplatin resistance of bladder cancer stem cells. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/26.

11. Kobayashi S, Fujii Y, Koga F, Yokoyama M, Sakura M, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H, Kihara K. Impact of bladder neck involvement on progression in patients with non-muscle invasive bladder cancer: a validation study. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/27.

12. Tatokoro M, Masuda H, Kijima T, Yoshida S, Sakura M, Yokoyama M, Saito K, Koga F, Fujii Y, Kawakami S, Kihara K. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus Aureus (MRSA) in a urology ward possibly due to avoidance of antimicrobial prophylaxis in minimally invasive surgery: Our 11-year trial. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

13. Kijima T, Masuda H, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Kihara K. Antimicrobial prophylaxis is avoidable in minimally invasive partial nephrectomy without entry into the urinary tract. The 27th Annual Congress of the European Association of Urology, Paris, France, 2012/2/25.

米国泌尿器科学会（annual meeting of the American Urological Association）

1. Yokoyama M, Fujii Y, Takeshita H, Sakura M, Ishioka J, Iimura Y, Saito K, Koga F, Masuda H, Noro A, Kihara K. Development and validation of predictive models for renal function after radical nephrectomy. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

2. Yokoyama M, Fujii Y, Takeshita H, Iimura Y, Saito K, Koga F, Masuda H, Noro A, Kihara K. Longitudinal recovery of renal function up to 10 years after radical nephrectomy The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

3. Kihara K, Koga F, Masuda H, Saito K, Tatokoro M, Yokoyama M, Matsuoka Y, Numao N, Kawakami S, Fujii Y. Gasless single-port clampless partial nephrectomy for peripheral renal tumor: Surgical, short-term oncological, and functional outcomes. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

4. Kijima T, Masuda H, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Kihara K. Antimicrobial prophylaxis is not necessary in minimally invasive partial nephrectomy without entry into the urinary tract. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

5. Masuda H, Kawakami S, Ito M, Takeshita H, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yamamoto S, Fukui I, Kihara K. Performance of free PSA mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

6. Kihara K, Masuda H, Saito K, Koga F, Numao N, Matsuoka Y, Ishioka J, Yokoyama M, Sakura M, Fujii Y. Gasless laparoendoscopic single-port retroperitoneal radical nephrectomy in dialysis patients: perioperative outcomes of 82 consecutive cases. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

7. Tatokoro M, Masuda H, Kijima T, Yoshida S, Sakura M, Yokoyama M, Saito K, Koga F, Kawakami S, Fujii Y, Kihara K. Successful control of Methicillin-resistant Staphylococcus aureus in a urology ward possibly due to avoidance of antimicrobial prophylaxis in minimally invasive surgery: our 11 years trial. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

8. Numao N, Yoshida S, Komai Y, Ishii C, Kagawa M, Matsuoka Y, Koga F, Saito K, Masuda H, Kawakami S, Kihara K Prebiopsy multi-parametric MRI potentially reduces unnecessary prostate biopsy in men with PSA less than 10 ng/mL and a normal digital rectal examination. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

9. Takeshita H, Numao N, Kawakami S, Sakura M, Yokoyama M, Ishioka J, Matusoka Y, Koga F, Saito K, Masuda H, Yamamoto S, Yonese J, Ishikawa Y, Fukui I, Kihara K. Characteristics of prostate cancers missed by initial transperineal extended biopsy The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/23

10. Matsuoka Y, Numao N, Saito K, Tanaka H, Kijima T, Kobayashi S, Tatokoro M, Sakura M, Yokoyama M, Ishioka J, Koga F, Masuda H, Kihara K. Combination of 14-core biopsy and magnetic resonance imaging can identify appropriate candidates for hemiablative focal therapy of prostate cancer. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/20

11. Kagawa M, Masuda H, Kawakami S, Ito M, Takeshita H, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yamamoto S, Fukui I, Kihara K. Better performance of plasma volume than body mass index for high-grade prostate cancer detection at extended biopsy in Japanese men. The 106th annual meeting of the American Urological Association, Atlanta, GA, USA, 2012/05/21

米国臨床癌学会泌尿生殖器癌シンポジウム（American Society of Clinical Oncology, Genitourinary Cancers Symposium）

1. Ishioka J, Saito K, Sakura M, Yokoyama M, Matsuoka Y, Numao N, Koga F, Masuda H, Kihara K. A contribution of C-reactive protein to predict overall survival in patients with advanced urothelial carcinoma: Development of a nomogram and evaluation by decision curve analysis. The 2012 Genitourinary Cancer Symposium, San Francisco, CA, 2012/2/2.

1. Fukushima H, Tatokoro M, Saito K, Fujii Y, Sakura M, Numao N, Koga F, Masuda H, Yamada H, Kihara K. Diagnostic contribution of C-reactive protein kinetics for gastric metastasis from renal cell carcinoma. Int Cancer Conf J . 1:93-95, 2012.

2. Fukushima H, Masuda H, Kawakami S, Ito M, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yamamoto S, Yonese J, Fukui I, Kihara K. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology 79: 1329-34, 2012.PubMed

3. Ishioka J, Saito K, Sakura M, Yokoyama M, Matsuoka Y, Numao N, Koga F, Masuda H, Fujii Y, Kawakami S, Kihara K. Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Br J Cancer. 107:1031-6，2012．PubMed

4. Kihara K, Fujii Y, Masuda H, Saito K, Koga F, Matsuoka Y, Numao N, Kojima K. New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy. Int J Urol. 19: 886-9, 2012.PubMed

5. Kihara K. Application of gasless laparoendoscopic single port surgery, GasLESS, to partial nephrectomy for renal cell carcinoma: GasLESS-clampless partial nephrectomy as a multiply satisfactory method. Int J Urol. 19: 3-4, 2012.PubMed

6. Kijima T, Masuda H, Yoshida S, Tatokoro M, Yokoyama M, Numao N, Saito K, Koga F, Fujii Y, Kihara K. Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients. Urology. 80:570-5, 2012.PubMed

7. Koga F, Fujii Y, Masuda H, Numao N, Yokoyama M, Ishioka J, Saito K, Kawakami S, Kihara K. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches. BJU Int. 110: E203-E208, 2012.PubMed

8. Koga F, Kihara K, Yoshida S, Yokoyama M, Saito K, Masuda H, Fujii Y, Kawakami S. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: Oncological outcomes of the initial 46 cases. BJU Int . 109: 860-866, 2012．PubMed

9. Komai Y, Kawakami S, Numao N, Fujii Y, Saito K, Kubo Y, Koga F, Kumagai J, Yamamoto S, Yonese J, Ishikawa Y, Fukui I, Kihara K. Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer. BJU Int. 110: E564-9, 2012.PubMed

10. Inamura K, Fujiwara M, Togashi Y, Nomura K, Mukai H, Fujii Y, Yamamoto S, Yonese J, Fukui I, Ishikawa Y. Diverse Fusion Patterns and Heterogeneous Clinicopathologic Features of Renal Cell Carcinoma With t(6;11) Translocation. Am J Surg Pathol. 36: 35-42, 2012. PubMed

11. Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 11: 3649-55, 2012.PubMed

12. Masuda H, Kawakami S, Sakura M, Fujii Y, Koga F, Saito K, Numao N, Yonese J, Fukui I, Kihara K. Performance of prostate-specific antigen mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia. Int J Urol. 19:929-35, 2012.PubMed

13. Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, Koga F, Masuda H, Kawakami S, Fujii Y, Kihara K. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol, 65: 186-92, 2014. PubMed

14. Nakanishi　Y, Masuda　H, Kawakami　S, Sakura　M, Fujii　Y, Saito　K, Koga　F, Ito　M, Yonese　J, Fukui　I, Kihara　K． A novel equation and nomogram including body weight for estimating prostate volumes in men with biopsy-proven benign prostatic hyperplasia. Asian Journal of Andrology . 14: 703-7, 2012.PubMed

15. Numao N, Kawakami S, Sakura M, Yoshida S, Koga F, Saito K, Masuda H, Fujii Y, Yamamoto S, Yonese J, Ishikawa Y, Fukui I, Kihara K. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int. 109: 665-71, 2012.PubMed

16. Saito K, Urakami S, Komai Y, Yasuda Y, Kubo Y, Kitsukawa S, Okubo Y, Yamamoto S, Yonese J, Fukui I. Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin. BJU Int. 110: 1478-84, 2012.PubMed

17. Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K. Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer. 118: 4427-36. 2012.PubMed

18. Takazawa R, Kitayama S, Tsujii T. Successful outcome of flexible ureteroscopy with holmium laser lithotripsy for renal stones 2 cm or greater. Int J Urol. 19: 264-7, 2012. PubMed

19. Takazawa R, Kitayama S, Tsujii T. Single-session ureteroscopy with holmium laser lithotripsy for multiple stones. Int. J. Urol. 19: 1118-1121, 2012.PubMed

20. Takeshita H, Amemiya M, Chiba K, Urushibara M, Satoh J, Noro A. Disseminated kidney tuberculosis complicating autosomal dominant polycystic kidney disease: a case report. Clin Nephrol. 77:242-5, 2012.PubMed

21. Takeshita H, Yokoyama M, Fujii Y, Chiba K, Ishioka J, Noro A, Kihara K. Impact of renal function on cardiovascular events in patients undergoing radical nephrectomy for renal cancer. Int J Urol. 19:722-8, 2012.PubMed

22. Tatokoro M, Koga F, Yoshida S, Kawakami S, Fujii Y, Neckers L, Kihara K. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer . 131: 987-996, 2012．PubMed

23. Tsutsumi S, Mollapour M, Prodromou C, Lee CT, Panaretou B, Yoshida S, Mayer MP, Neckers LM. Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proc Natl Acad Sci U S A. 109: 2937-42, 2012.PubMed

24. Yamamoto S, Kawakami S, Yonese J, Fujii Y, Urakami S, Masuda H, Numao N, Ishikawa Y, Kohno A, Fukui I. Long-term Oncological Outcome and Risk Stratification in Men with High-risk Prostate Cancer Treated with Radical Prostatectomy. Jpn J Clin Oncol . 42: 541-547, 2012.PubMed

25. Yoshida S, Koga F, Kobayashi S, Ishii C, Tanaka H, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 83: e21-7, 2012PubMed

26. Waseda Y, Komai Y, Yano A, Fujii Y, Noguchi N, Kihara K. Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report. Jpn J Clin Oncol. 42: 1197-201, 2012.PubMed

27. 影山幸雄、河野友亮、福井直隆、東四雄、田部井敏夫．当センターにおける術中輸血回避の実績．　埼玉県医学会雑誌 47(1):215-218,2012.

28. 木島敏樹、木原和徳．導尿法　臨床研修手技・処置．　ベッドサイド手帖，奈良信雄　植竹宏之編、medical view社，東京， pp214-217, 2012.

29. 木原和徳．嚢胞性腎疾患．今日の治療指針．山口　徹、北原光夫編集，医学書院，東京， p950-951, 2012.

30. 木原和徳．前立腺癌手術の過去～未来：社会に適した新ロボット手術へ．泌尿器外科　25(特別）: 543-545, 2012．

31. 河野友亮、福井直隆、影山幸雄、東四雄：前立腺全摘後鼠径ヘルニア予防における単純精索剥離の効果．　泌尿器科紀要　58:415－420,2012．

32. 河野友亮、福井直隆、影山幸雄、東四雄、田部井敏夫．転移性腎癌に対しテムシロリムスによる治療を行い重症肺感染症で死亡した1例．埼玉県医学会雑誌　47(1):211-214，2012．

33. 古賀文隆、木原和徳．膀胱癌、病気・病態・重症度からみた疾患別看護過程＋病態関連図．第２版　井上智子、佐藤千史編集，　医学書院，東京， pp894—899、2012.

34. 齋藤一隆、木原和徳．腎腫瘍（腎細胞癌）、病気・病態・重症度からみた疾患別看護過程+病態関連図． 第２版　井上智子、佐藤千史編集，医学書院，東京， pp864—868，2012.

35. 齋藤一隆、木原和徳．進行性腎盂尿管癌に対するミニマム創内視鏡下腎尿管全摘除（ガスレス・２ポート腎尿管全摘除）．泌尿器外科　25(4): 677-683, 2012.

36. 齋藤一隆，古賀文隆，増田　均，藤井靖久，木原和徳．Central/hilar renal tumor に対するミニマム創内視鏡下腎部分切除：シングルポート（コイン創）/ガスレス/腹膜外/無阻血・冷阻血アプローチ．日本ミニマム創泌尿器内視鏡外科学会雑誌　4( 1)： 123-126，2012

37. 沼尾　昇、竹下英毅、中西泰一、松岡　陽、古賀文隆、齋藤一隆、増田　均、藤井靖久、藍原有弘、伴　大輔、小林宏寿、小嶋一幸、木原和徳. ミニマム創内視鏡下手術の教育システム. 日本ミニマム創泌尿器内視鏡外科学会雑誌　4 (1): 55-58, 2012 ．

38. 黄　鼎文、福井直隆、河野友亮、影山幸雄、東　四雄．ＧＣ療法におけるシスプラチン１時間投与法についての検討．　泌尿器外科　24(11)：1782-1784, 2012．

39. 福井直隆、黄　鼎文、河野友亮、影山幸雄、東　四雄．パドル電極を用いたソフト凝固による腎部分切除術．臨床泌尿器科　66(2):157-161, 2012.

40. 福島啓司, 古賀文隆, 田所　学, 横山みなと, 齋藤一隆, 増田　均, 藤井靖久, 川上　理, 木原和徳. 転移巣に対する低用量化学放射線療法を主体とする集学的治療が奏効した腎盂原発小細胞癌の1例. 日本泌尿器科学会雑誌　102:638-43, 2012．

41. 藤井靖久，木原和徳，川上　理，山本真也，米瀬淳二，福井　巌．前立腺全摘術後の鼠径ヘルニア発症を防止する腹膜鞘状突起切断法：ミニマム創内視鏡下手術への導入．Audio-Visual Journal of JUA　 18: vol 2, 2012．

42. 松岡　陽、木原和徳、斎藤一隆、古賀文隆、増田　均、藤井靖久．腹腔鏡下小切開手術施設基準医認定について．日本ミニマム創泌尿器内視鏡外科学会雑誌　4(1): 31-34, 2012.

43. 松岡　陽、斎藤一隆、木原和徳．海外学会における腫瘍トピックス―EAU 2012― 限局性前立腺癌の治療．泌尿器外科　25(6): 1297-1299, 2012.

44. 横山みなと, 古賀文隆, 増田　均, 木原和徳. 海外学会における腫瘍トピックス -EAU 2012- 限局性腎癌の診断および治療. 泌尿器外科　25:1201-2, 2012.

45. 横山みなと、藤井靖久、木原和徳. 各種病態にみられる腎障害 感染症 感染性心内膜炎. 別冊日本臨床　18: 656-8. 2012．

46. 吉永敦史，岡田洋平，一柳暢孝，鎌田成芳．前立腺癌内分泌療法中に増悪する骨病変を契機に発見された多発性骨髄腫の2例．泌尿器科紀要　58:243-248, 2012．

47. 吉永敦史，一柳暢孝，鎌田成芳．重症尿路感染症による敗血症性ショックを呈した2例の治療経験．救急医学　36:1598-1601, 2012．

1. Koga F, Kihara K. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review. Int J Urol. 19:388-401, 2012.PubMed

2. Saito K, Kihara K. C-reactive protein as a biomarker for urological cancers. Nat Rev Urol. 8: 659-66, 2012.PubMed

3. Yuasa T, Fujii Y, Takahashi S, Fukui I, Yonese J. Molecular Targeted Therapies for Patients with Metastatic Renal Cell Cancer. Translational Medic S2: (web journal) 2012.

4. Yuasa T, Yamamoto S, Urakami S, Fukui I, Yonese J. Denosumab: a new option in the treatment of bone metastases from urological cancers. Onco Targets Ther. 5:221-9. 2012.PubMed

5. 影山幸雄．pT1膀胱がんに対する膀胱全摘．泌尿器外科 25(臨時増刊）:903-904, 2012.

6. 木原和徳． 前立腺癌治療最前線　根治手術ーミニマム創　適応と根拠、テクニック、QOLを含めた成績、今後の展望．カレントテラピー 2012．

7. 木原和徳．ミニマム創内視鏡下手術（ガスレス・シングルポート）手術の海外普及2011：中国への普及．日本ミニマム創泌尿器内視鏡外科学会雑誌 4:79-82，2012.

8. 木原和徳．ミニマム創内視鏡下手術におけるコイン創化と術者のロボット化：Gasless Single-port RoboSurgeon-type Surgeryの開発．日本ミニマム創泌尿器内視鏡外科学会雑誌 4:71-77, 2012.

9. 木原和徳、増田　均．前立腺癌の根治手術：ミニマム創内視鏡下手術．カレントテラピー30　2012．

10. 古賀文隆，齋藤一隆，増田　均，藤井靖久，木原和徳. Peripheral renal tumor に対するミニマム創内視鏡下腎部分切除：シングルポート（コイン創）／ガスレス／腹膜外／無阻血アプローチ．日本ミニマム創内視鏡下外科学会雑誌 4(2): 119-122, 2012.

11. 田所　学、木原和徳．自己管理および在宅医療のための機器と治療法の発展 自己導尿．成人病と生活習慣病 42:438-441，2012．

12. 沼尾 昇、齋藤一隆、木原和徳. EAU2012で示された前立腺癌の診断に関するトピックス. 泌尿器外科 25 (6): 1295-1296, 2012.

13. 藤井靖久．分子標的薬によるpresurgical治療の意義はあるか？(特集　進行性腎癌に対する分子標的治療薬・薬剤選択ガイド）．臨床泌尿器科 66: 43-48, 2012.

14. 藤井靖久、砂倉瑞明、増田　均、米瀬淳二．がん研有明病院におけるミニマム創内視鏡下手術（腹腔鏡下小切開手術）の導入．日本ミニマム創内視鏡下外科学会雑誌 4(2): 79-84, 2012.

15. 藤井靖久．転移巣に対する外科的治療，放射線治療 (第10章　泌尿器科腫瘍：進行性腎がんの治療）．日本泌尿器科学会 2012年卒後教育テキスト 17: 201-205, 2012.

16. 藤井靖久．転移性腎癌に対する薬物治療-サイトカイン療法 (第10章　泌尿器科腫瘍：進行性腎がんの治療）．日本泌尿器科学会 2012年卒後教育テキスト 17: 206-209, 2012．

17. 藤井靖久，木原和徳．腹腔鏡下小切開（ミニマム創内視鏡下）腎部分切除（ナースも知っておきたい　最近保険収載された泌尿器科手術）．泌尿器ケア 18: 91-94, 2012．

18. 増田　均.　＜学会指定プログラム2＞ 「下部尿路症状」の性差‐要因について‐．日本女性医学学会雑誌，20（1）：228-230．

19. 米瀬 淳二. 【リンパ節郭清の現状と可能性】 陰茎がんにおける鼠径リンパ節転移の診断治療．泌尿器外科 25: 1963-1968, 2012.

20. 米瀬淳二．【尿路変向術の術式Q&A】 回腸導管造設術．泌尿器ケア 17: 1030-1034, 2012.

21. 米瀬 淳二. 術式別にみた術前・術後管理 根治的腎摘除術,腎部分切除術,腎尿管全摘除術(開放手術). 臨床泌尿器科 66: 341-4, 2012.

22. 米瀬淳二．指導的助手からみた泌尿器科手術のポイント 前立腺全摘術(恥骨後式)．臨床泌尿器科 66:129-34,2012.

1. 影山幸雄．尿路感染症（腎盂腎炎・膀胱炎）．井上智子、佐藤千史編集、疾患別看護過程＋病態関連図．医学書院， 東京，937-949, 2012．

2. 北原聡史．腎・尿管結石（腎結石・尿管結石・膀胱結石）、病期・病態・重症度から見た疾患別看護過程＋病態関連図．　第２版　井上智子／佐藤千史編　医学書院，　東京，876-882，2012．

3. 北原聡史．精巣性女性化症候群、内分泌代謝専門医ガイドブック　改訂３版　成瀬光栄／平田結喜緒／島津章編　診断と治療社，266-267, 2012．

4. 古賀文隆，木原和徳. 第8章　泌尿・生殖器疾患　48．膀胱癌. 病期・病態・重症度からみた疾患別看護過程．第２版　井上智子／佐藤千史編，医学書院，東京, 894-909, 2012.

5. 増田　均．7. 手術療法　CQ7ミニマム創内視鏡下前立腺全摘除術はどのような利点・欠点があるのか？ 前立腺癌 診療ガイドライン 2012年版, 134-136, 日本泌尿器科学会編, 金原出版, 東京, 2012.

1. 第5回日本ミニマム創泌尿器内視鏡外科学会、東京、2012年12月15, 16日．

1. 古賀文隆．科学研究費補助金：基盤(C) 23501266．膀胱癌の転移／治療耐性における p63 蛋白の役割．文部科学省．

2. 田所　学．科学研究費補助金：若手 (B) 23791744　尿路上皮癌幹細胞の同定および癌幹細胞をターゲットとした治療モデルの構築．文部科学省．

3. 横山みなと. 科学研究費助成金　若手研究(B)．根治的腎摘除後の腎機能予測モデルの構築および外部検証. 文部科学省．